LDN-211904 oxalate (compound 32) 是一种有效的选择性EphB3抑制剂，IC50为 0.079 μM。LDN-211904 oxalate 在小鼠肝微粒体中表现出良好的代谢稳定性。LDN-211904 oxalate 与西妥昔单抗联用可有效抑制 STAT3 激活的 CSC 干性和 CRC 中的西妥昔单抗耐药性。
| 生物活性 | LDN-211904 oxalate (compound 32) is a potent and selectiveEphB3inhibitor with anIC50of 0.079 μM. LDN-211904 oxalate shows good metabolic stability in mouse liver microsomes. LDN-211904 oxalate with cetuximab could be effective in inhibiting STAT3-activated CSC stemness and cetuximab resistance in CRC[1][2]. |
| IC50& Target | IC50: 0.079 μM (EphB3)[1] |
| 分子量 | |
| 性状 | |
| Formula | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | | Powder | -20°C | 3 years | | In solvent | -80°C | 6 months | | -20°C | 1 month |
|
